Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open study for the evaluation of the effectiveness of insulin buccal spray on metabolic control in patients with impaired glucose tolerance (PREVORAL study 2) [Studio aperto per la valutazione dell efficacia dell insulina spray buccale sul controllo glicometabolico in soggetti con ridotta tolleranza ai carboidrati (studio PREVORAL 2)]

Trial Profile

Open study for the evaluation of the effectiveness of insulin buccal spray on metabolic control in patients with impaired glucose tolerance (PREVORAL study 2) [Studio aperto per la valutazione dell efficacia dell insulina spray buccale sul controllo glicometabolico in soggetti con ridotta tolleranza ai carboidrati (studio PREVORAL 2)]

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin (Primary)
  • Indications Glucose intolerance; Hyperglycaemia; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PREVORAL2

Most Recent Events

  • 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
  • 05 Oct 2012 Status changed from active, no longer recruiting to completed, based on the abstract presented at EASD.
  • 08 Dec 2011 Results presented at the 21st World Diabetes Congress.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top